Search Prime Grants

U19FD007124

Cooperative Agreement

Overview

Grant Description
Hawaii's Fern Microbiology Laboratory's role in keeping human food products safe.
Awardee
Hawaii Department Of Health
Funding Goals
TO ASSIST INSTITUTIONS AND ORGANIZATIONS, TO ESTABLISH, EXPAND, AND IMPROVE RESEARCH, DEMONSTRATION, EDUCATION AND INFORMATION DISSEMINATION ACTIVITIES, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), BIOLOGICS, BLOOD AND BLOOD PRODUCTS, THERAPEUTICS, VACCINES AND ALLERGENIC PROJECTS, DRUG HAZARDS, HUMAN AND VETERINARY DRUGS, CLINICAL TRIALS ON DRUGS AND DEVICES FOR ORPHAN PRODUCTS DEVELOPMENT, NUTRITION, SANITATION AND MICROBIOLOGICAL HAZARDS, MEDICAL DEVICES AND DIAGNOSTIC PRODUCTS, RADIATION EMITTING DEVICES AND MATERIALS, FOOD SAFETY AND FOOD ADDITIVES. THESE PROGRAMS ARE SUPPORTED DIRECTLY OR INDIRECTLY BY THE FOLLOWING CENTERS AND OFFICES: CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), CENTER FOR VETERINARY MEDICINE (CVM), CENTER FOR FOOD SAFETY AND APPLIED NUTRITION (CFSAN), NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR), THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT (OPD), THE CENTER FOR TOBACCO PRODUCTS (CTP), AND OFFICE OF REGULATORY AFFAIRS (ORA), AND THE OFFICE OF THE COMMISSIONER (OC). SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAMS: TO STIMULATE TECHNOLOGICAL INNOVATION, TO ENCOURAGE THE ROLE OF SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION BY MINORITY AND DISADVANTAGED PERSONS IN TECHNOLOGICAL INNOVATION. FUNDING SUPPORT FOR SCIENTIFIC CONFERENCES THAT ARE RELEVANT TO THE FDA SCIENTIFIC MISSION AND PUBLIC HEALTH ARE ALSO AVAILABLE.
Grant Program (CFDA)
93.103 - Food and Drug Administration Research
Awarding Agency
FDA Office of Acquisition and Grant Services (OAGS) [HHS - FDA]
Funding Agency
FDA Office of Regulatory Affairs (ORA) [HHS - FDA]
Place of Performance
Hawaii United States
Geographic Scope
State-Wide
Related Opportunity
Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed (PAR-20-105)
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/25 to 03/31/26 and the total obligations have increased 240% from $370,120 to $1,259,747.
Hawaii Department Of Health was awarded Hawaii's FERN Microbiology Laboratory's Role in Keeping Human Food Products Safe Cooperative Agreement U19FD007124 worth $1,259,747 from the FDA Office of Regulatory Affairs in September 2020 with work to be completed primarily in Hawaii United States. The grant has a duration of 5 years 6 months and was awarded through assistance program 93.103 Food and Drug Administration Research. The Cooperative Agreement was awarded through grant opportunity Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed.

Status
(Ongoing)

Last Modified 6/5/25

Period of Performance
9/1/20
Start Date
3/31/26
End Date
91.0% Complete

Funding Split
$1.3M
Federal Obligation
$0.0
Non-Federal Obligation
$1.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U19FD007124

Transaction History

Modifications to U19FD007124

Additional Detail

Award ID FAIN
U19FD007124
SAI Number
U19FD007124-3629736961
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75FDA1 FDA Office of Acquisitions and Grants Services
Funding Office
75DLLR FDA OFFICE OF REGULATORY AFFAIRS
Awardee UEI
LFVFLBD6XZB5
Awardee CAGE
1M0S1
Performance District
HI-90
Senators
Mazie Hirono
Brian Schatz

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) Consumer and occupational health and safety Grants, subsidies, and contributions (41.0) $785,288 100%
Modified: 6/5/25